Antibiotic resistance, virulence, and genetic background of community-acquired uropathogenic Escherichia coli from Algeria

Microbial Drug Resistance

Volumn 21, Issue 5, 2015, Pages 516-526

  Yahiaoui, Merzouk ^a   Robin, Frédéric ^b,c   Bakour, Rabah ^a   Hamidi, Moufida ^d   Bonnet, Richard ^b,c   Messai, Yamina ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

^d Department of Neurosurgery   (Algeria)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN; AZTREONAM; BETA LACTAMASE AMPC; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CEFALOTIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTAZIDIME; CEFTRIAXONE; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; DNA TOPOISOMERASE (ATP HYDROLYSING) A; ERTAPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; NALIDIXIC ACID; NETILMICIN; OFLOXACIN; PEFLOXACIN; PROTEIN PARC; SULFONAMIDE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT; BETA LACTAM; BETA LACTAMASE; DNA TOPOISOMERASE (ATP HYDROLYSING); DNA TOPOISOMERASE IV; QUINOLONE DERIVATIVE;

ADULT; ALGERIA; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; CLADISTICS; FEMALE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; INTEGRON; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; UROPATHOGENIC ESCHERICHIA COLI; AGED; CLASSIFICATION; COMMUNITY ACQUIRED INFECTION; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; GENE EXPRESSION; GENETICS; GENOTYPE; METABOLISM; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; MUTATION; PATHOGENICITY; PATHOLOGY; PHYLOGENY; POLYMERASE CHAIN REACTION; VIRULENCE;

ADULT; AGED; ALGERIA; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; COMMUNITY-ACQUIRED INFECTIONS; DNA GYRASE; DNA TOPOISOMERASE IV; DRUG RESISTANCE, MULTIPLE, BACTERIAL; ESCHERICHIA COLI INFECTIONS; FEMALE; FLUOROQUINOLONES; GENE EXPRESSION; GENOTYPE; HUMANS; INTEGRONS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MULTILOCUS SEQUENCE TYPING; MUTATION; PHYLOGENY; POLYMERASE CHAIN REACTION; SULFONAMIDES; TRIMETHOPRIM; UROPATHOGENIC ESCHERICHIA COLI; VIRULENCE;

EID: 84943257168     PISSN: 10766294     EISSN: 19318448     Source Type: Journal    
DOI: 10.1089/mdr.2015.0045     Document Type: Article

References (65)

1. Alghoribi, M.F., T.M. Gibreel, A.R. Dodgson, S.A. Beatson, andM. Upton. 2014. Galleria mellonella infection model demonstrates high lethality of ST69 and ST127 uropathogenic E. coli. PLos One 9:e101547.
2. Anderson, G.G., C.C. Goller, S. Justice, S.J. Hultgren, and P.C. Seed. 2010. Polysaccharide capsule and sialic acid-mediated regulation promote biofilm-like intracellular bacterial communities during cystitis. Infect. Immun. 78: 963-975.
3. Anssour, L., Y. Messai, M. Derkaoui, S. Alouache, V. Estepa, S. Somalo, C. Torres, and R. Bakour. 2014. ESBL, plasmidic AmpC, and associated quinolone resistance determinants in coliforms isolated from hospital effluent: first report of qnrB2, qnrB9, qnrB19, and blaCMY-4 in Algeria. J. Chemother. 26:74-79.
4. Banerjee, R., B. Johnston, C. Lohse, S. Chattopadhyay, V. Tchesnokova, E.V. Sokurenko, and J.R. Johnson. 2013. The clonal distribution and diversity of extraintestinal Escherichia coli isolates vary according to patient characteristics. Antimicrob. Agents Chemother. 57:5912-5917.
5. Bansal, S., and V. Tandon. 2011. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates. Int. J. Antimicrob. Agents 37:253-255.
6. Bidet, P., S. Bonacorsi, O. Clermont, C. De Montille, N. Brahimi, and E. Bingen. 2005. Multiple insertional events, restricted by the genetic background, have led to acquisition of pathogenicity island IIJ96-like domains among Escherichia coli strains of different clinical origins. Infect. Immun. 73:4081-4087.
7. Blahna, M.T., C.A. Zalewski, J. Reuer, G. Kahlmeter, B. Foxman, and C.F. Marrs. 2006. The role of horizontal gene transfer in the spread of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli in Europe and Canada. J. Antimicrob. Chemother. 57:666-672.
8. Bonnet, R. 2004. Growing group of extended-spectrum b-lactamases: the CTX-M enzymes. Antimicrob. Agents Chemother. 48:1-14.
9. Cantón, R., J.M. González-Alba, and J.C. Galán. 2012. CTX-M enzymes: origin and diffusion. Front. Microbiol. 3:1-19.
10. Clermont, O., H. Dhanji, M. Upton, T. Gibreel, A. Fox, D. Boyd, M.R. Mulvey, P. Nordmann, E. Ruppé, J.L. Sarthou, T. Frank, S. Vimont, G. Arlet, C. Branger, N. Woodford, and E. Denamur. 2009. Rapid detection of the O25b-ST131 clone of Escherichia coli encompassing the CTX-M-15-producing strains. J. Antimicrob. Chemother. 64:274-277.
11. Clermont, O., J.K. Christenson, E. Denamur, and D.M. Gordon. 2013. The Clermont Escherichia coli phylotyping method revisited: improvement of specificity and detection of new phylo-groups. Environ. Microbiol. Rep. 5:58-65.
12. Corvec, S., A. Prodhomme, C. Giraudeau, S. Dauvergne, A. Reynaud, and N. Caroff. 2007. Most Escherichia coli strains overproducing chromosomal AmpC b-lactamase belong to phylogenetic group A. J. Antimicrob. Chemother. 60:872-876.
13. Croxen, M.A., and B.B. Finlay. 2010. Molecular mechanisms of Escherichia coli pathogenicity. Nature Rev. Microbiol. 8:26-38.
14. Dalhoff, A. 2012. Global fluoroquinolone resistance epidemiology and implications for clinical use. Interdiscip. Perspect. Infect. Dis. 2012:1-37.
15. Dhakal, B. K., R.R. Kulesus, and M.A. Mulvey. 2008. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur. J. Clin. Invest. 38 Suppl 2:2-11.
16. Dhakal, B.K., and M.A. Mulvey. 2012. The UPEC pore forming toxin a-hemolysin triggers proteolysis of host proteins to disrupt cell adhesion, inflammatory and survival pathways. Cell Host Microbe 11:58-69.
17. Ding, J., X. Ma, Z. Chen, and K. Feng. 2013. b-Lactamases in amoxicillin-clavulanate-resistant Escherichia coli strains isolated from a Chinese tertiary hospital. Diagn. Microbiol. Infect. Dis. 76:532-533.
18. El Fertas-Aissani, R., Y. Messai, S. Alouache, and R. Bakour. 2013. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol. Biol. 61:209-216.
19. Ewers, C., A. Bethe, T. Semmler, S. Guenther, and L.H. Wieler. 2012. Extended-spectrum b-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. Clin. Microbiol. Infect. 18: 646-655.
20. Fabre, R., A. Mérens, F. Lefebvre, G. Epifanoff, F. Cerutti, H. Pupin, D. Tardif, J.-D. Cavallo, and I. Ternois. 2010. Sensibilité aux antibiotiques des Escherichia coli isolés d'infections urinaires communautaires. Med. Mal. Infect. 40:555-559.
21. Fàbrega, A., S. Madurga, E. Giralt, and J. Vila. 2009. Mechanism of action and resistance to quinolones. Microb. Biotechnol. 2:40-61.
22. Foxman, B. 2010.The epidemiology of urinary tract infection. Nat. Rev. Urol. 7:653-660.
23. Frank, T., V. Gautier, A. Talarmin, R. Bercion, and G. Arlet. 2007. Characterization of sulphonamide resistance genes and class 1 integron gene cassettes in Enterobacteriaceae, Central African Republic (CAR). J. Antimicrob. Chemother. 59:742-745.
24. Garcia, E.C., A.R. Brumbaugh, and H.L.T. Mobley. 2011. Redundancy and specificity of Escherichia coli iron acquisition systems during urinary tract infection. Infect. Immun. 79:1225-1235.
25. Garénaux, A., M. Caza, and C.M. Dozois. 2011. The Ins and Outs of siderophore mediated iron uptake by extraintestinal pathogenic Escherichia coli. Vet. Microbiol. 153:89-98.
26. Gillings, M.R. 2014. Integrons: past, present, and future. Microbiol. Mol. Biol. Rev. 78:2257-2277.
27. Guardabassi, L., and H. Kruse. 2008. Principles of prudent and rational use of antimicrobials in animals. In L. Guardabassi, L.B. Jensen, and H. Kruse (eds.), Guide to Antimicrobial Use in Animals. Blackwell Publishing, Ltd., Oxford, UK, pp. 1-12.
28. Gupta, K., T.M. Hooton, K.G. Naber, B. Wullt, R. Colgan, L.G. Miller, G.J. Moran, L.E. Nicolle, R. Raz, A.J. Schaeffer, and D.E. Soper. 2011. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin. Infect. Dis. 52:e103-e120.
29. Ho, P.-I., K.-S. Yip, K.-H. Chow, J.Y.C. Lob, T.-L. Que, and K.-Y. Yuen. 2010. Antimicrobial resistance among uropathogens that cause acute uncomplicated cystitis in women in Hong Kong: a prospective multicenter study in 2006 to 2008. Diagn. Microbiol. Infect. Dis. 66:87-93.
30. Hopkins, K.L., R.H. Davies, and E.J. Threlfall. 2005. Mechanisms of quinolone resistance in Escherichia coli and Salmonella: Recent developments. Int. J. Antimicrob. Agents 25:358-373.
31. Jauréguy, F., E. Carbonnelle, S. Bonacorsi, C. Clec'h, P. Casassus, E. Bingen, B. Picard, X. Nassif, and O. Lortholary. 2007. Host and bacterial determinants of initial severity and outcome of Escherichia coli sepsis. Clin. Microbiol. Infect. 13:854-862.
32. Johnson, J.R., and A.L. Stell. 2000. Extended virulence genotypes of Escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J. Infect. Dis. 181:261-272.
33. Johnson, J.R., B. Johnston, M.A. Kuskowski, J.-P. Nougayrede, and E. Oswald. 2008. Molecular epidemiology and phylogenetic distribution of the Escherichia coli pks genomic island. J. Clin. Microbiol. 46:3906-3911.
34. Karami, N., F. Nowrouzian, I. Adlerberth, and A.E. Wold. 2006. Tetracycline resistance in Escherichia coli and persistence in the infantile colonic microbiota. Antimicrob. Agents Chemother. 50:156-161.
35. Kim, H.B.,M.Wang, C.H. Park, E.-C. Kim, G.A. Jacoby, and D.C. Hooper. 2009. oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae. Antimicrob. Agents Chemother. 53:3582-3584.
36. Lee, M.Y., H.J. Choi, J.Y. Choi, M. Song, Y. Song, S.-W. Kim, H.-H. Chang, S.-I. Jung, Y.-S. Kim, H.K. Ki, J.S. Son, K.T. Kwon, S.T. Heo, J.-S. Yeom, S.Y. Shin, D.R. Chung, K.R. Peck, J.-H. Song, and K.S. Ko. 2010. Dissemination of ST131 and ST393 community onset, ciprofloxacin-resistant Escherichia coli clones causing urinary tract infections in Korea. J. Infect. 60:146-153.
37. Lemonnier, M., L. Landraud, and E. Lemichez. 2007. Rho GTPase-activating bacterial toxins: frombacterial virulence regulation to eukaryotic cell biology. FEMS Microbiol. Rev. 31:515-534.
38. Linhares, I., T. Raposo, A. Rodrigues, and A. Almeida. 2013. Frequency and antimicrobial resistance patterns of bacteria implicated in community urinary tract infections: a ten-year surveillance study (2000-2009). BMC Infect. Dis. 13:19.
39. Maraki, S., E. Mantadakis, L. Michailidis, and G. Samonis. 2013. Changing antibiotic susceptibilities of community acquired uropathogens in Greece, 2005-2010. J. Microbiol. Immunol. Infect. 46:202-209.
40. Martín, O., A. Valverde, M.I. Morosini, M. Rodríguez-Domínguez, M. Rodríguez-Banõs, T.M. Coque, R. Cantón, and R. del Campo. 2010. Population analysis and epidemiological features of inhibitor-resistant-TEM-blactamase-producing Escherichia coli isolates from both community and hospital settings in Madrid, Spain. J. Clin. Microbiol. 48:2368-2372.
41. Martinez, P., D. Garzón, and S. Mattar. 2012. CTX-Mproducing Escherichia coli and Klebsiella pneumoniae isolated from community-acquired urinary tract infections in Valledupar, Colombia. Braz. J. Infect. Dis. 16:420-425.
42. Melican, K., R.M. Sandoval, A. Kader, L. Josefsson, G.A. Tanner, B.A. Molitoris, and A. Richter-Dahlfors. 2011. Uropathogenic Escherichia coli P and type 1 fimbriae act in synergy in a living host to facilitate renal colonization leading to nephron obstruction. PLoS Pathogens. 7:e1001298.
43. Messai, Y., H. Iabadene, T. Benhassine, S. Alouache, M. Tazir, V. Gautier, G. Arlet, and R. Bakour. 2008. Prevalence and characterization of extended-spectrum betalactamases in Klebsiella pneumoniae in Algiers hospitals (Algeria). Pathol. Biol. (Paris). 56:319-325.
44. Mulvey, M.R., E. Bryce, D.A. Boyd, M. Ofner-Agostini, A.M. Land, A.E. Simor, S. Paton; the Canadian Hospital Epidemiology Committee and the Canadian Nosocomial Infection Surveillance Program, Health Canada. 2005. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals. Antimicrob. Agents Chemother. 49:358-365.
45. Naves, P., G. del Prado, L. Huelves, M. Gracia, V. Ruiz, J. Blanco, G. Dahbi, M. Blanco, M. del Carmen Ponte, and F. Soriano. 2008. Correlation between virulence factors and in vitro biofilm formation by Escherichia coli strains. Microb. Pathog. 45:86-91.
46. Nordstrom, L., C.M. Liu, and L.B. Price. 2013. Foodborne urinary tract infections: a new paradigm for antimicrobial-resistant foodborne illness. Front. Microbiol. 4:1-6.
47. Nowrouzian, F.L., and E. Oswald. 2012. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carry the potentially genotoxic pks island. Microb. Pathog. 53:180-182.
48. Qi, C., V. Pilla, J.H. Yu, and K. Reed. 2010. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum b-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn. Microbiol. Infect. Dis. 67: 87-91.
49. Rahal, K., R. Belouni, H. Tali-Maamar, M. Boudouane, M.F.K. Missoum, A. Benslimani, and A. Aboun. 2012. 13ème rapport d'évaluation ( Janvier à Décembre 2011): Surveillance de la résistance des bactéries aux antibiotiques. Ministère de la Santé, Algérie (in French).
50. Restieri, C., G. Garriss, M.-C. Locas, and C.M. Dozois. 2007. Autotransporter-encoding sequences are phylogenetically distributed among Escherichia coli clinical isolates and reference strains. Appl. Environ. Microbiol. 73: 1553-1562.
51. Riley, L.W. 2014. Pandemic lineages of extraintestinal pathogenic Escherichia coli. Clin. Microbiol. Infect. 20: 380-390.
52. Rogers, B.A., H.E. Sidjabat, and D.L. Paterson. 2011. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J. Antimicrob. Chemother. 66:1-14.
53. Ruiz-Perez F., R. Wahid, C.S. Faherty, K. Kolappaswamy, L. Rodriguez, A. Santiago, E. Murphy, A. Cross, M.B. Sztein, and J.P. Nataro. 2011. Serine protease autotransporters from Shigella flexneri and pathogenic Escherichia coli target a broad range of leukocyte glycoproteins. Proc. Natl. Acad. Sci. U. S. A. 108:12881-12886.
54. Šeputien- e, V., J. Povilonis, M. Ruzauskas, A. Pavilonis, and E. Suzied-eliene. 2010. Prevalence of trimethoprim resistance genes in Escherichia coli isolates of human and animal origin in Lithuania. J. Med. Microbiol. 59:315-322.
55. Soufi, L., Y. Sáenz, L. Vinué, M.S. Abbassi, E. Ruiz, M. Zarazaga, A. Ben Hassen, S. Hammami, and C. Torres. 2011. Escherichia coli of poultry food origin as reservoir of sulphonamide resistance genes and integrons. Int. J. Food Microbiol. 144:497-502.
56. Srinivasan, U., B. Foxman, and C.F. Marrs. 2003. Identification of a gene encoding heat-resistant agglutinin in Escherichia coli as a putative virulence factor in urinary tract infection. J. Clin. Microbiol. 41:285-289.
57. Strahilevitz, J., G.A. Jacoby, D.C. Hooper, and A. Robicsek. 2009. Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22:664-689.
58. Subashchandrabose, S., S.N. Smith, R.R. Spurbeck, M.M. Kole, and H.L.T. Mobley. 2013. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathogens. 9:e1003788.
59. Totsika, M., D.G. Moriel, A. Idris, B.A. Rogers, D.J. Wurpel, M.-D. Phan, D.L. Paterson, and M.A. Schembri. 2012. Uropathogenic Escherichia coli mediated urinary tract infection. Curr. Drug Targets 13:1386-1399.
60. Tracz, D.M., D.A. Boyd, R. Hizon, E. Bryce, A. McGeer, M. Ofner-Agostini, A.E. Simor, S.P., M.R. Mulvey; the Canadian Nosocomial Infection Surveillance Program. 2007. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates. FEMS Microbiol. Lett. 270:265-271.
61. Vincent, C., P. Boerlin, D. Daignault, C.M. Dozois, L. Dutil, C. Galanakis, R.J. Reid-Smith, P.-P. Tellier, P.A. Tellis, K. Ziebell, and A.R. Manges. 2010. Food reservoir for Escherichia coli causing urinary tract infections. Emerg. Infect. Dis. 16:88-95.
62. Vogeleer, P., Y.D.N. Tremblay, A.A. Mafu, M. Jacques, and J. Harel. 2014. Life on the outside: role of biofilms in environmental persistence of Shiga-toxin producing Escherichia coli. Front. Microbiol. 5:1-12.
63. Woodford, N., J.F. Turton, and D.M. Livermore. 2011. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35:736-755.
64. Wright, K.J., P.C. Seed, and S.J. Hultgren. 2007. Development of intracellular bacterial communities of uropathogenic Escherichia coli depends on type 1 pili. Cell. Microbiol. 9:2230-2241.
65. Xia, X., J. Meng, P.F. McDermott, and S. Zhao. 2011. Escherichia coli from retail meats carry genes associated with uropathogenic Escherichia coli, but are weakly invasive in human bladder cell culture. J. Appl. Microbiol. 110:1166-1176.